ASKA Pharmaceutical Holdings Co (TSE:4886) Other Net Income (Loss) : 円-1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Other Net Income (Loss)?

ASKA Pharmaceutical Holdings Co's Other Net Income (Loss) for the three months ended in Dec. 2023 was 円1 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was 円-1 Mil.

ASKA Pharmaceutical Holdings Co's quarterly Other Net Income (Loss) increased from Jun. 2023 (円-1 Mil) to Sep. 2023 (円0 Mil) and increased from Sep. 2023 (円0 Mil) to Dec. 2023 (円1 Mil).

ASKA Pharmaceutical Holdings Co's annual Other Net Income (Loss) declined from Mar. 2022 (円0 Mil) to Mar. 2023 (円-1 Mil) but then stayed the same from Mar. 2023 (円-1 Mil) to Mar. 2024 (円-1 Mil).

ASKA Pharmaceutical Holdings Co Other Net Income (Loss) Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Other Net Income (Loss) Chart

ASKA Pharmaceutical Holdings Co Annual Data

Trend

Mar22

Mar23

Mar24

Other Net Income (Loss)

-1.00

ASKA Pharmaceutical Holdings Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial							-1.00	-1.00	-	1.00	-1.00

ASKA Pharmaceutical Holdings Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1 Mil.

ASKA Pharmaceutical Holdings Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532

Website

https://www.aska-pharma-hd.co.jp

ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines